FDA Requires Boxed Warning for Risk of T-Cell Malignancies With Approved CAR T-Cell Therapies
The FDA has mandated that the boxed warning for all approved CAR T-cell therapies be updated to include the serious risk of T-cell malignancies.
The FDA has mandated that the boxed warning for all approved CAR T-cell therapies be updated to include the serious risk of T-cell malignancies.
James Cribbin and his wife, Alexandra, came to MD Anderson for its expertise in marginal zone lymphoma, a rare subtype of non-Hodgkin lymphoma. What they…
Healio is accepting submissions for its third annual peer-recognition program, Healio Honors. The goal of the program is to celebrate health care professionals who go…
Valentin Ortiz-Maldonado, MD, Hospital Clinic Barcelona, Barcelona, Spain, discusses strategies for preventing relapse in patients with B-cell acute lymphoblastic leukemia (B-ALL) in both the pre…
TAR-200 displayed a high complete response rate in Bacillus Calmette–Guérin-unresponsive high-risk non–muscle-invasive bladder cancer.
Wolters Kluwer (“we” or “us”) wants to inform you about the ways we process your personal information. In this Privacy & Cookie Notice we explain…
This study of 5-year follow-up data from a phase 2 clinical trial examines the association of response with 12 induction instillations of bacillus Calmette-Guèrin (BCG)…
About 4% of US cancer survivors surveyed said they adhere to the American Cancer Society’s nutrition and physical activity guidelines.
This review assesses current evidence and emerging treatment strategies for improved survival among patients with metastatic hormone-sensitive prostate cancer and offers recommendations for clinical practice…
Ocular melanoma is very different from melanoma skin cancer. Read about this rare form of melanoma also known as uveal melanoma.
Dostarlimab plus chemotherapy has been granted priority review from the FDA to expand its indication to all adult patients with primary advanced or recurrent endometrial…